Genenta Science S.p.A. (GNTA)

NASDAQ: GNTA · Real-Time Price · USD

3.100

+0.055 (1.81%)

Jun 27, 2025, 4:00 PM - Market closed

Genenta Science Employees

Genenta Science had 13 employees as of December 31, 2024. The number of employees decreased by 1 or -7.14% compared to the previous year.

Employees

13

Change (1Y)

-1

Growth (1Y)

-7.14%

Revenue / Employee

n/a

Profits / Employee

-$709,780

Market Cap

56.70M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	13	-1	-7.14%
Dec 31, 2023	14	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

GNTA News

7 weeks ago - Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference - Newsfile Corp
7 weeks ago - Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies - GlobeNewsWire
2 months ago - Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewsWire
3 months ago - Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates - GlobeNewsWire
5 months ago - TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
6 months ago - Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewsWire
6 months ago - ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
8 months ago - Genenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” - GlobeNewsWire